Insmed Incorporated Shares Are Trading Lower. The Company Announced Additional Results From the ASPEN Study of Brensocatib in Patients With Non-cystic Fibrosis Bronchiectasis.
Insmed Incorporated Shares Are Trading Lower. The Company Announced Additional Results From the ASPEN Study of Brensocatib in Patients With Non-cystic Fibrosis Bronchiectasis.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.